03 February 2025
03 February 2025
L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.
If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.
The CDMO has not disclosed how many employees will be affected by the operational wind down.
Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro and Zepbound.
This removal of IRP was described by the Federal Ministry of Health (FMoH) as a natural consequence of changes allowing confidential discounted reimbursement prices.
Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products.
Gross profit for the quarter stood at €7.84bn, up on €7.43bn in the same period of 2023.
The authorisation is based on week 24 data from an ongoing Phase I/II trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
